Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prucalopride for Postoperative Ileus in Colorectal Surgery
NCT06816407Phase 3Recruiting
- Sponsor
- Future University in Egypt
- Start
- Mar 2025
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of prucalopride in postoperative ileus (POI) (3 arms), sponsored by Future University in Egypt. Primary endpoints: Time to first stool at 7 days and Time to tolerance of food at 7 days. Started Mar 2025; status: recruiting.
02
Drugs
prucalopride
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT06816407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06816407.